Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 21, 2005; 11(47): 7436-7443
Published online Dec 21, 2005. doi: 10.3748/wjg.v11.i47.7436
Published online Dec 21, 2005. doi: 10.3748/wjg.v11.i47.7436
Figure 6 Incidence of intestinal metaplasia distant from the anastomosis site (A) and esophageal adenocarcinoma (B).
The risk of both intestinal metaplasia and adenocarcinoma was significantly lower in the SOD-treated group than in the control group (P = 0.046 and P = 0.021, respectively) (n = 6-10).
- Citation: Piazuelo E, Cebrián C, Escartín A, Jiménez P, Soteras F, Ortego J, Lanas A. Superoxide dismutase prevents development of adenocarcinoma in a rat model of Barrett’s esophagus. World J Gastroenterol 2005; 11(47): 7436-7443
- URL: https://www.wjgnet.com/1007-9327/full/v11/i47/7436.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i47.7436